MO10000 and ELFLIQ: LOST MARY and ELFBAR's New Products in Middle East Market

Elfbar by 2FIRSTS.ai

Jan.23.2024

MO10000 and ELFLIQ: LOST MARY and ELFBAR's New Products in Middle East Market

LOST MARY and ELFBAR, leading e-cigarette brands, are introducing new products MO10000 and ELFLIQ to the Middle East market.

According to a report from PR Newswire on January 22nd, leading global e-cigarette brands LOST MARY and ELFBAR have officially introduced their new products, the MO10000 e-cigarette and ELFLIQ e-liquid, to the Middle East market. These two new offerings are aimed at the development of the Middle East region and will be showcased alongside ELFBAR's BC10000 at the Middle East e-cigarette exhibition in 2024 (MEVS 2024).

ELFBAR's BC10000 made its debut in November 2023 in the United Arab Emirates and Saudi Arabia, catering to the local users' demand for a large-puff e-cigarette.

LOST MARY's MO10000 is equipped with a new atomization solution that allows for a larger mouthpiece and offers a variety of flavors. Additionally, the MO10000 also features real-time power and e-liquid displays, making it convenient for users to access information about e-cigarette usage.

ELFLIQ e-liquid made its debut in the Middle East, introducing 12 flavors to expand the product range of ELFBAR in the region.

References:

[1] LOST MARY and ELFBAR present new vape products in Middle East

Also Read:

[1] Top 10 Brands Launching Their Own E-liquids: ELFBAR, LOST MARY, SKE, VUSE, ELUX, etc.

[2] Cancellation of "Lady Mary" Trademark Requested by Disposable Manufacturer

[3] Google Search's Top 5 E-Cig Brands in December: LOST MARY Top, ELFBAR 5th

#E-liquids #Middle East #Products #E-cigarette Market #Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting

The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.

Nov.24 by 2FIRSTS.ai

Indonesian Police to Crack Down on Etomidate-Laced Vapes

Indonesia’s National Police Criminal Investigation Department (Bareskrim Polri) will continue to take enforcement action against users and distributors of etomidate-laced vape liquids, even though the substance is not yet classified as a narcotic. Brigadier General Eko Hadi Santoso, Director of Narcotics Crimes, said etomidate is an anaesthetic drug regulated under Health Law No. 17 of 2023, but has not been listed as a narcotic or psychotropic substance.

Oct.23 by 2FIRSTS.ai

ceshi1111

Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st

Oct.21

Tasmania, Australia Will Introduce New Laws Targeting Illegal Vape and Tobacco Retailers

Tasmania will introduce new laws next year to tackle the illegal trade in tobacco and vapes. The legislation will strengthen penalties, allow inspectors to issue on-the-spot fines and shut down non-compliant retailers, and enhance coordination between police and health authorities.